This course provides an update on newly approved topical medications for the treatment of glaucoma and ocular hypertension. Emphasis is placed on each drug’s indications, contraindications, adverse effects, efficacy, and cost.
Speaker: Phillip Yuhas, OD
Date: Wednesday, September 23, 2026
Time: 5:30 PM - 6:30 PM Pacific Time
Location: Virtual
Moderator: Dr. Carolyn Majcher
Cost: Free!
COPE ID: 106418-GL
Category: Glaucoma
This event is COPE approved for 1 hour of CE credit.
Established in 2019, Thea Pharma is the United States subsidiary of Laboratoires Théa, a global leader and pioneer in ophthalmics. We are committed to serve doctors that treat the anterior segment and ocular surface conditions.
